Back to Results
First PageMeta Content
Nitriles / Non-nucleoside reverse transcriptase inhibitors / Pyrimidines / Health / Pandemics / Darunavir / Antiretroviral drug / HIV / Rilpivirine / HIV/AIDS / Chemistry / Organic chemistry


Global HIV Access & Partnerships Program GAPP Status: Optimizing Use of Our HIV Medicines in Resource-Limited Countries AT JANSSEN, we are committed to helping people living with HIV in resource-limited settings by ensur
Add to Reading List

Document Date: 2012-07-18 12:14:17


Open Document

File Size: 245,14 KB

Share Result on Facebook

Company

Resource Limited / St. Stephens AIDS Trust / Janssen Global Services LLC / /

Continent

Europe / /

Country

Zimbabwe / Lesotho / Rwanda / Thailand / Senegal / Kenya / Zambia / Uganda / United States / Malawi / Tanzania / Nigeria / Botswana / United Kingdom / Ghana / Ethiopia / Mozambique / South Africa / Swaziland / Namibia / Cameroon / /

Event

Business Partnership / /

IndustryTerm

HIV Treatment / HIV therapies / e-initiatives / Treatment of AIDS / Therapy for HIV / /

MedicalCondition

HIV / diseases / AIDS / /

MedicalTreatment

Antiretroviral Treatment / Antiretroviral Therapy / /

Organization

Congress / World Health Organization / Botswana HIV Clinicians Society / Mwanza Intervention Trials Unit / Joint Clinical Research Center / /

Product

INTELENCE / PREZISTA / HIV / /

Region

sub-Saharan Africa / Asia Pacific / /

Technology

Pharmacokinetics / /

URL

www.janssenrnd.com / /

SocialTag